Ronda E Stryker

Ronda E Stryker (Director) sold 310,000 shares for $96.8M across 6 transactions on 2026-05-26; stock down 20.8% in 90 days.

Ronda E Stryker executed six separate sales totaling 310,000 shares for $96,792,668.92, reducing her holdings from 2,910,815 shares to 2,600,815 shares (-10.6%). The sales were priced between $310.77 and $315.11 with a blended average of $312.23. Over her cross-ticker history, this insider's 20 prior sells have produced an average 90-day return of -17.0% with a 90.00% well-timed rate; at SYK specifically, all 5 prior sales executed on 2026-02-05 resulted in negative 90-day returns ranging from -19.1% to -20.3%. The current stock price of $305.94 is down 24.4% from its 52-week high of $404.87 and down 20.8% over the past 90 days. This pattern of consistent pre-decline selling, when considered against the subsequent price deterioration and the company's elevated P/E of 35.17, reflects a track record of transaction timing aligned with subsequent weakness.

Director Ronda Stryker sold 500,000 SYK shares for $181.7M across 18 transactions Feb 4–5; 18.5% holdings reduction.

Director Ronda E. Stryker executed 18 separate sales totaling 500,000 shares for $181,719,268.58 on February 4–5, 2026, reducing her holdings by 500,000 shares (-18.5% vs pre-transaction holdings of 2,707,331 shares). The blended average sale price was $363.44, compared to the current market price of $358.29, placing the transaction 11.2% below the 52-week high of $403.53. Her prior trades at SYK (5 sells on 2025-11-06) showed a 0 of 5 well-timed rate at the 90-day mark, with average 90-day returns of +1.8% to +3.1%, meaning the stock subsequently rose after those prior sales. The company trades at a P/E of 46.53 with annual revenue growth of +10.2% and recent quarterly net income of $859.0M on $6.1B revenue. The scale and multi-tranche execution suggest a material reduction in her equity stake at relatively stable prices over two trading days.

Director Ronda Stryker sold 520,000 shares for $184.6M across 14 transactions over two days at blended average $355.01

Director Ronda E. Stryker executed 14 separate sales totaling 520,000 shares (520.0K shares) for $184,606,140.89 on November 5-6, 2025, reducing her stake from 3,222,108 shares (3.22M shares) to 2,702,108 shares (2.70M shares), a -16.1% reduction in holdings. The sales occurred at prices ranging from $349.95 to $359.79, with a blended average price of $355.01, just below the current price of $356.03. Her prior sales at SYK show consistent well-timing: all 5 of 5 prior sells at this ticker were well-timed at the 90-day mark (negative 90d returns ranging from -3.8% to -4.7%), suggesting systematic outperformance in the timing of exits. Her cross-ticker track record spans 20 prior sells with a 70.00% well-timed rate and a 90d average return of -2.8%, further supporting a pattern of disciplined sell execution. The scale of this transaction—$184.6M in a two-day window—and the demonstrated timing precision in prior SYK sales merit investor attention to whether this signals a shift in her conviction or positioning relative to the company's valuation (trading at a 46.24 P/E).

Director Ronda Stryker sells 200,000 SYK shares in 8 transactions totaling $75.3M at average $376.45

Director Ronda Stryker executed 8 separate sales totaling 200,000 shares (200.0K shares) for $75,289,655.38 ($75.3M) on 2025-08-06, reducing her holdings by 5.8% to 3,222,108 shares (3.22M shares). The sale prices ranged from $374.99 to $380.63 per share, with a blended average price of $376.45, occurring near the current price of $376.37. At the same-ticker level, Stryker's prior 5 sales at SYK (all conducted on 2025-05-06) showed 0 well-timed outcomes at the 90-day mark, indicating her historical timing decisions at this ticker have not preceded price declines; her cross-ticker track record shows a 30% well-timed rate across 20 prior sells. The scale of this liquidation—a substantial dollar amount representing a meaningful reduction in an already-large executive position—occurs with the stock trading 6.7% below its 52-week high and down 3.4% over 30 days, against a backdrop of strong fundamental metrics (revenue $6.0B, P/E 49.33, annual growth +10.2%).

Director Ronda Stryker sold 200,000 shares for $75.4M; prior 5 SYK sales all well-timed at 90-day mark.

On 2025-05-06, STRYKER RONDA E, a Director at Stryker Corp, executed 6 separate sales totaling 200,000 shares for $75,391,847.90 at a blended average price of $376.96. The transaction reduced her holdings from 3.62M to 3.42M shares (-5.5%). Notably, her prior 5 trades at SYK (all on 2025-01-31) were all well-timed at the 90-day mark, with negative 90-day returns ranging from -4.3% to -5.5%, suggesting a track record of selling before declines at this specific ticker. The current price of $382.46 is 4.4% below the 52-week high ($399.90) and up 13.4% over the past 30 days, indicating the stock has recovered after the 2025-01-31 sales. This filing merits monitoring to assess whether the current May 2025 sale follows the same well-timed pattern observed in her recent SYK transaction history.

Director Stryker sold 201,392 shares (5.2% reduction) for $78,993,068.38 on 2025-01-31

Ronda E. Stryker, a Director at Stryker Corp, executed 6 separate sales on 2025-01-31, divesting 201,392 shares (201.4K shares) for $78,993,068.38 ($79.0M) at prices ranging from $390.90 to $395.60, with a blended average of $392.24. This represented a 5.2% reduction of her pre-transaction holdings (from 3.84M shares to 3.64M shares). The transactions occurred as SYK traded within 2.2% of its 52-week high of $399.90, suggesting the sales occurred at elevated valuations. Her prior 5 sales at SYK (all on 2024-11-05) showed positive 30-day and 90-day returns, with none well-timed at the 90-day horizon—a pattern indicating the stock continued higher after those sales. The company trades at a P/E of 41.52 with $5.5B quarterly revenue and +11.1% annual growth, but the timing and scale of this divestiture warrant scrutiny given the proximity to the 52-week highs and lack of well-timed exits in her same-ticker history.

Director Stryker Ronda E sold 230,000 shares for $84.5M on 2024-11-05 at $367.37 avg, leaving 3.09M shares

Director Ronda E Stryker executed 8 separate sales totaling 230,000 shares for $84,494,989.68 on 2024-11-05, at a blended average price of $367.37, reducing her holdings by 6.9% to 3,086,608 shares. The transaction occurred within 0.6% of the stock's 52-week high of $371.96, at a point where the stock had gained 5.4% over 30 days and 12.8% over 90 days. Her prior 5 sales at SYK in August 2024 all failed to precede declines, with 90-day returns ranging from +13.7% to +15.8%, indicating her recent timing at this ticker has been poorly positioned relative to subsequent stock performance. The current valuation of the company (P/E 39.26, revenue growth +11.1% YoY) and the sale's proximity to yearly highs provide context but do not resolve whether this sale reflects transaction-specific timing or scheduled activity.

Director Ronda E. Stryker sells 190,000 shares (5.4% of holdings) for $61.5M across 10 transactions at blended $323.46

Director Ronda E. Stryker executed 10 separate sales totaling 190,000 shares for $61.5M on 2024-08-06, reducing her stake from 3.51M to 3.32M shares (a 5.4% decrease). The sale occurred near the upper range of recent trading activity, with transactions executed between $316.95 and $326.06 per share at a blended average of $323.46, just 0.77% below the current price of $325.99. Her prior trades at SYK show a 5 of 5 pattern of well-timed sells at the 90-day mark, with all resulting in negative 90-day returns ranging from -5.5% to -4.1%, suggesting this insider has demonstrated consistent ability to identify selling opportunities. The combination of substantial transaction size, price execution near recent highs, and a track record of well-timed exits at this specific ticker warrants investor attention, particularly given SYK's premium 36.02 P/E valuation and -9.1% year-to-date decline from its 52-week high.